← Open Payments lookup

MUTIAT POPOOLA: Open Payments

NPI 1477169936 · BRANDYWINE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$567 in 15 payments from 7 companies in 2025. Trend: 2023 $88 · 2024 $301 · 2025 $567

Food & beverage: $567
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.6$214
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$139
Teva Pharmaceuticals USA, Inc.1$120
Lundbeck LLC2$31
E.R. Squibb & Sons, L.L.C.1$28
Otsuka America Pharmaceutical, Inc.1$21
ABBVIE INC.1$15

Products named: INGREZZA, CAPLYTA, UZEDY, REXULTI, COBENFY, VRAYLAR.

Industry payments across MD — which companies pay providers there.